172 related articles for article (PubMed ID: 7697598)
1. The simultaneous occurrence of variant hairy cell leukemia and chronic-phase chronic myelogenous leukemia. A case report.
Reeves JE; Robbins BA; Pankey LR; Elias AL; Anderson WF
Cancer; 1995 Apr; 75(8):2089-92. PubMed ID: 7697598
[TBL] [Abstract][Full Text] [Related]
2. Complete hematologic remissions in chronic-phase, Philadelphia-chromosome-positive, chronic myelogenous leukemia after 2-chlorodeoxyadenosine.
Saven A; Piro LD; Lemon RH; Figueroa ML; Kosty M; Ellison DJ; Beutler E
Cancer; 1994 Jun; 73(12):2953-63. PubMed ID: 7911068
[TBL] [Abstract][Full Text] [Related]
3. Chronic myeloid leukaemia occurring in a patient with hairy cell leukaemia.
Wandroo FA; Bareford D; el-Jehani F
J Clin Pathol; 2000 Dec; 53(12):940-1. PubMed ID: 11265181
[TBL] [Abstract][Full Text] [Related]
4. 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia.
Yang MH; Ho CH
Zhonghua Yi Xue Za Zhi (Taipei); 2001 Jan; 64(1):54-8. PubMed ID: 11310372
[TBL] [Abstract][Full Text] [Related]
5. Coexistence of chronic myeloid leukemia and hairy cell leukemia of common clonal origin.
Pajor L; Kereskai L; Tamáska P; Vass JA; Radványi G
Cancer Genet Cytogenet; 2002 Apr; 134(2):114-7. PubMed ID: 12034522
[TBL] [Abstract][Full Text] [Related]
6. Chronic myeloid leukaemia and hairy cell leukaemia coexisting in a single patient: difficulties at diagnosis and rational of the therapeutic strategy.
Orciuolo E; Fazzi R; Galimberti S; Testi C; Azzara' A; Carulli G; Petrini M
Leuk Res; 2006 Mar; 30(3):349-53. PubMed ID: 16182365
[TBL] [Abstract][Full Text] [Related]
7. Three hematologic malignancies in the same patient: chronic lymphocytic leukemia, followed by chronic myeloid leukemia and acute myeloid leukemia.
Fattizzo B; Radice T; Cattaneo D; Pomati M; Barcellini W; Iurlo A
Clin Lab; 2014; 60(11):1929-32. PubMed ID: 25648037
[TBL] [Abstract][Full Text] [Related]
8. [A case of chronic myeloid leukemia occurring during treatment for chronic lymphocytic leukemia].
Hattori H; Kuwayama M; Kotake T; Karasuno T
Gan To Kagaku Ryoho; 2011 Feb; 38(2):333-6. PubMed ID: 21368508
[TBL] [Abstract][Full Text] [Related]
9. Hairy cell leukemia variant in a patient with chronic myeloid leukemia receiving nilotinib: sequential or coincidental?
Gopaluni S; Sanyal S; Bair A; Vajpayee N
J Clin Oncol; 2012 Feb; 30(5):e58-61. PubMed ID: 22184394
[No Abstract] [Full Text] [Related]
10. Flow cytometry of peripheral blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells, lymphocyte subsets and detection of minimal residual disease after treatment.
Babuŝíková O; Tomová A; Kusenda J; Gyárfás J
Neoplasma; 2001; 48(5):350-7. PubMed ID: 11845978
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous homoharringtonine and interferon-alpha in the treatment of patients with chronic-phase chronic myelogenous leukemia.
O'Brien S; Talpaz M; Cortes J; Shan J; Giles FJ; Faderl S; Thomas D; Garcia-Manero G; Mallard S; Beth M; Koller C; Kornblau S; Andreeff M; Murgo A; Keating M; Kantarjian HM
Cancer; 2002 Apr; 94(7):2024-32. PubMed ID: 11932905
[TBL] [Abstract][Full Text] [Related]
12. An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2-chlorodeoxyadenosine.
Jehn U; Bartl R; Dietzfelbinger H; Haferlach T; Heinemann V
Leukemia; 2004 Sep; 18(9):1476-81. PubMed ID: 15229616
[TBL] [Abstract][Full Text] [Related]
13. Hairy cell leukemia 1992.
Spielberger RT; Golomb HM
Leukemia; 1992 Nov; 6 Suppl 4():142-6. PubMed ID: 1279327
[TBL] [Abstract][Full Text] [Related]
14. Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
Steinberg M
Clin Ther; 2007 Nov; 29(11):2289-308. PubMed ID: 18158072
[TBL] [Abstract][Full Text] [Related]
15. Combined treatment with splenectomy and cladribine in hairy cell leukemia in Taiwan: a clinicopathologic study of 5 cases.
Yu YB; Li CY; Chen CC; You JY; Chau WK; Hsu HC; Gau JP; Chen PM; Ho CH
J Chin Med Assoc; 2007 Dec; 70(12):551-5. PubMed ID: 18194897
[TBL] [Abstract][Full Text] [Related]
16. Sequestration of Philadelphia chromosome-positive cells in the bone marrow of a chronic myeloid leukemia patient in very prolonged remission.
Birnie GD; MacKenzie ED; Goyns MH; Pollock A
Leukemia; 1990 Jun; 4(6):452-4. PubMed ID: 2359346
[No Abstract] [Full Text] [Related]
17. Imatinib mesylate therapy reduces bone marrow fibrosis in patients with chronic myelogenous leukemia.
Bueso-Ramos CE; Cortes J; Talpaz M; O'Brien S; Giles F; Rios MB; Medeiros LJ; Kantarjian H
Cancer; 2004 Jul; 101(2):332-6. PubMed ID: 15241831
[TBL] [Abstract][Full Text] [Related]
18. Minimal residual disease in hairy-cell leukemia after treatment with 2-chlorodeoxyadenosine.
Konwalinka G; Schirmer M; Hilbe W; Fend F; Geisen F; Knoblechner A; Petzer A; Thaler J
Blood Cells Mol Dis; 1995; 21(2):142-51. PubMed ID: 8846043
[TBL] [Abstract][Full Text] [Related]
19. Hairy cell leukemia and variant in Taiwan: report of a variant case and literature review.
Hsieh YC; Chang ST; Chuang SS; Lu CL; Tsao CJ; Lin CN; Li CY
Int J Clin Exp Pathol; 2011 Jan; 4(2):183-9. PubMed ID: 21326814
[TBL] [Abstract][Full Text] [Related]
20. Five years follow-up after 2-chloro deoxyadenosine treatment in thirty patients with hairy cell leukemia: evaluation of minimal residual disease and CD4+ lymphocytopenia after treatment.
Bastie JN; Cazals-Hatem D; Daniel MT; D'Agay MF; Rabian C; Glaisner S; Noel-Walter MP; Dabout D; Flandrin G; Dombret H; Poisson D; Degos L; Castaigne S
Leuk Lymphoma; 1999 Nov; 35(5-6):555-65. PubMed ID: 10609793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]